Even modest amounts of walking – as few as 3,000 steps a day – may help protect against Alzheimer’s by reducing harmful tau ...

A new study suggests that many women with early-stage breast cancer may not need radiation after a mastectomy, thanks to ...

The results of a late-stage drug trial released Thursday are raising hopes that type 1 diabetes patients with chronic kidney ...

Cannformatics Inc., a biotechnology company advancing the use of metabolic biomarkers and artificial intelligence to personalize medical cannabis treatment, today announced that a proof-of-concept ...

Weill Cornell researchers uncovered how free radicals from astrocyte mitochondria can fuel dementia. Using new compounds that ...

November is Alzheimer’s Awareness Month, a time to spotlight the growing impact of the disease across the United States and ...

Researchers say the new state-funded institute could speed discoveries, prevention efforts and treatments for ...

New diagnostic kits aim to revolutionize early screening of the disease, potentially allowing patients to receive ...

If approved by voters, the $3 billion investment could spark groundbreaking discoveries in Texas labs and reshape how the ...

A groundbreaking trial to explore the potential of blood tests to diagnose dementia has begun at North Bristol NHS Trust, in collaboration with the University of Bristol. The research study marks a ...

FDA feedback enables CervoMed to proceed with proposed endpoints, patient enrichment strategy, and other key aspects of Phase 3 trial design to support potential New Drug Application ...

Texans are voting on 17 constitutional amendments Tuesday, one of which involves creating a new state agency dedicated to researching dementia.